Latest Alzinova News & Updates

See the latest news and media coverage for Alzinova. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alzinova

Clinical-stage biopharma developing Alzheimer's immunotherapy

alzinova.com
Headquarters
Gothenburg, Sweden
Founded year
2011
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Alzinova

In short: Alzinova advanced its ALZ-101 Alzheimer’s vaccine toward Phase II trials, secured funding via a rights issue, and expanded diagnostic partnerships.

Company announcements

Alzinova

Alzinova’s CEO presents path forward

He discusses Phase II preparations for ALZ-101 and ongoing rights issue to fund CMC and regulatory work.

Unlock all announcements with a

Media coverage

FinanzNachrichten

Alzinova AB: Alzinova's Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH...

Unlock all articles with a

Never miss news about Alzinova

Track Alzinova and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alzinova competitors & trending companies

Browse news for competitors to Alzinova and other trending companies.